House Ways & Means health subcommittee Chair Peter Roskam (R-IL) is now open to making plans factor in rebates and pharmacy price concessions at the point of sale, and drug makers and pharmacists in separate meetings this week urged CMS to adopt that approach after the agency said it has the power to do so . However, insurers and pharmacy benefit managers say dictating how plans use rebates would be government interference in price negotiations and would do nothing to...